JP Morgan has recently reduced Precigen Inc (PGEN) stock to Underweight rating, as announced on March 22, 2024, according to Finviz. Earlier, on May 23, 2023, JP Morgan had initiated the stock to ...
Rosenblatt has recently raised Innoviz Technologies Ltd (INVZ) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on November 14, 2024, Cantor Fitzgerald had reduced ...
Hosted on MSN7h
Cantor Fitzgerald Initiates Coverage of aTyr Pharma (ATYR) with Overweight RecommendationFintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...
Cantor Fitzgerald reiterated their overweight rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research report released on Monday,Benzinga reports. Cantor Fitzgerald currently has a ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
The general mood among these heavyweight investors is divided, with 51% leaning bullish and 44% bearish. Among these notable ...
Rivian reports 14,183 EV deliveries in December quarter, analysts react. Cantor Fitzgerald reiterates Overweight with $13 ...
Equities research analysts at Cantor Fitzgerald started coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research report issued to clients and investors on Monday,Briefing.com ...
Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...
Cantor Fitzgerald analyst Kristen Kluska initiated coverage of Supernus (SUPN) with an Overweight rating and $57 price target Supernus has ...
The stock market is taking a breather after a relentless run, but opportunities still abound, according to some on Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback